These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2073922)

  • 1. Increased dopamine release by the autoreceptor antagonist (+)-AJ 76 is Ca2(+)-dependent.
    Waters N; Löfberg L; Svensson K; Carlsson A
    Eur J Pharmacol; 1990 Oct; 187(3):425-34. PubMed ID: 2073922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of a carrier transport process on in vivo release and metabolism of dopamine: dependence on extracellular Na+.
    Hurd YL; Ungerstedt U
    Life Sci; 1989; 45(4):283-93. PubMed ID: 2474734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis.
    Kurata K; Shibata R
    Pharmacology; 1991; 42(1):1-9. PubMed ID: 2057516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.
    Koulu M; Lappalainen J; Pesonen U; Hietala J; Syvälahti E
    Eur J Pharmacol; 1988 Oct; 155(3):313-6. PubMed ID: 3069483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.
    Svensson K; Johansson AM; Magnusson T; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):234-45. PubMed ID: 2880302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion.
    Hajos M; Hjorth S; Svensson K; Carlsson A
    Exp Brain Res; 1988; 70(3):577-84. PubMed ID: 3133239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus.
    Patrick SL; Thompson TL; Walker JM; Patrick RL
    Brain Res; 1991 Jan; 538(2):343-6. PubMed ID: 2012977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission.
    Hurd YL; Ungerstedt U
    Eur J Pharmacol; 1989 Jul; 166(2):261-9. PubMed ID: 2477260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen.
    Hurd YL; Ungerstedt U
    Eur J Pharmacol; 1989 Jul; 166(2):251-60. PubMed ID: 2477259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine.
    Janhunen S; Ahtee L
    Eur J Pharmacol; 2004 Jun; 494(2-3):167-77. PubMed ID: 15212971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure activity and hyperthermia potentiate the increases in dopamine and serotonin extracellular levels in the amygdala during exposure to d-amphetamine.
    Tor-Agbidye J; Yamamoto B; Bowyer JF
    Toxicol Sci; 2001 Mar; 60(1):103-11. PubMed ID: 11222877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of apomorphine-induced yawning in rats by the dopamine autoreceptor antagonist (+)-AJ 76.
    Dourish CT; Herbert EN; Iversen SD
    Neuropharmacology; 1989 Dec; 28(12):1423-5. PubMed ID: 2615920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of repeated administration of the preferential dopamine autoreceptor antagonist, (+)-AJ76, on locomotor activity and brain DA metabolism in the rat.
    Kullingsjö H; Carlsson A; Svensson K
    Eur J Pharmacol; 1991 Dec; 205(3):241-6. PubMed ID: 1817961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus.
    Jaskiw GE; Weinberger DR; Crawley JN
    Biol Psychiatry; 1991 Apr; 29(7):703-6. PubMed ID: 1711381
    [No Abstract]   [Full Text] [Related]  

  • 15. Does amphetamine preferentially increase the extracellular concentration of dopamine in the mesolimbic system of freely moving rats?
    Robinson TE; Camp DM
    Neuropsychopharmacology; 1990 Jun; 3(3):163-73. PubMed ID: 1694669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ontogeny of amphetamine-induced dopamine release in the caudate-putamen of the rat.
    Gazzara RA; Fisher RS; Howard SG
    Brain Res; 1986 Aug; 393(2):213-20. PubMed ID: 3742239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel development of dopamine metabolism tolerance in the rat prefrontal cortex, caudate-putamen, and amygdala following haloperidol decanoate administration.
    Kurachi M; Shibata R; Murata M; Tanii Y
    Biol Psychiatry; 1995 Apr; 37(7):487-90. PubMed ID: 7786966
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
    Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM
    Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
    Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
    Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.